1-4 of 4
Atsushi Tanaka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease

In Special Collection:
Thymus, T Cell Development, and Inborn Errors , Autoimmunity: From Novel Mechanisms to Treatments
Atsushi Tanaka, Shinji Maeda, Takashi Nomura, Mara Anais Llamas-Covarrubias, Satoshi Tanaka, Lin Jin, Ee Lyn Lim, Hiromasa Morikawa, Yohko Kitagawa, Shuji Akizuki, Yoshinaga Ito, Chihiro Fujimori, Keiji Hirota, Tosei Murase, Motomu Hashimoto, Junichi Higo, Rose Zamoyska, Ryuzo Ueda, Daron M. Standley, Noriko Sakaguchi, Shimon Sakaguchi
Journal: Journal of Experimental Medicine
J Exp Med (2022) 220 (2): e20220386.
https://doi.org/10.1084/jem.20220386
Published: 01 December 2022
View article titled, Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease
Open the PDF for Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease in another window
Includes: Supplementary data
Journal Articles

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells

In Special Collection:
2020 Update on Experimental Hematology , JEM 2020 Update on Cancer Immunology and Immunotherapy
Atsushi Tanaka, Hiroyoshi Nishikawa, Shinsuke Noguchi, Daisuke Sugiyama, Hiromasa Morikawa, Yoshiko Takeuchi, Danbee Ha, Naoya Shigeta, Toshio Kitawaki, Yuka Maeda, Takuro Saito, Yoshinori Shinohara, Yoshihiro Kameoka, Keiko Iwaisako, Fumihiko Monma, Kohshi Ohishi, Julia Karbach, Elke Jäger, Kenichi Sawada, Naoyuki Katayama, Naoto Takahashi, Shimon Sakaguchi
Journal: Journal of Experimental Medicine
J Exp Med (2019) 217 (2): e20191009.
https://doi.org/10.1084/jem.20191009
Published: 08 November 2019
View article titled, Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
Open the PDF for Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells in another window
Includes: Supplementary data
Journal Articles

Attracting AID to targets of somatic hypermutation

Atsushi Tanaka, Hong Ming Shen, Sarayu Ratnam, Prashant Kodgire, Ursula Storb
Journal: Journal of Experimental Medicine
J Exp Med (2010) 207 (2): 405–415.
https://doi.org/10.1084/jem.20090821
Published: 25 January 2010
View article titled, Attracting AID to targets of somatic hypermutation
Open the PDF for Attracting AID to targets of somatic hypermutation in another window
Includes: Supplementary data
Journal Articles

The very 5′ end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions

Simonne Longerich, Atsushi Tanaka, Grazyna Bozek, Dan Nicolae, Ursula Storb
Journal: Journal of Experimental Medicine
J Exp Med (2005) 202 (10): 1443–1454.
https://doi.org/10.1084/jem.20051604
Published: 21 November 2005
View article titled, The very 5′ end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions
Open the PDF for The very 5′ end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions in another window